1001-5094
2009 Issue 3
Quantitative Structure-pharmacokinetic Relationship in Drug Design and Discovery
LI Ting-ting;ZHAO Hong-ping;ZHENG Chao-nan;JI Hui;CHEN Xi-jing
LI Ting-ting;ZHAO Hong-ping;ZHENG Chao-nan;JI Hui;CHEN Xi-jing
..............page:97-103
Notch Signaling in Carcinogenesis and Cancer Therapy
MA Yan-jun;ZHAO Zhi-ming;LIU Jing-jing
MA Yan-jun;ZHAO Zhi-ming;LIU Jing-jing
..............page:104-111
Aplindore:a Dopamine Partial Agonist
fan ming
fan ming
..............page:141-142
..............page:140-141
..............page:139-140
Epratuzumab:a Humanized Anti-CD22 MAB
kang yin hua ; fan ming
kang yin hua ; fan ming
..............page:138-139
Preparation and Quality Control of Gatifloxacin Eye Drops
SHI Wen-xiang;MAO Zhi-ying;ZHANG Fa-cheng
SHI Wen-xiang;MAO Zhi-ying;ZHANG Fa-cheng
..............page:134-137
Superior Methodology for the Nitration of Pyrimidine and Pyridine Derivatives
WANG Xiao-chen;ZHANG Qi-hong;LI Ying-zi;TANG Chao-zhe;WANG Xun;ZHANG Qian;WANG Yong-bin;YAO Qi-zheng
WANG Xiao-chen;ZHANG Qi-hong;LI Ying-zi;TANG Chao-zhe;WANG Xun;ZHANG Qian;WANG Yong-bin;YAO Qi-zheng
..............page:131-133
High Glucose-induced Vascular Dysfunction and Expression of Vascular ETAR and OB-Rb:Intervention Effects of ETR Antagonist CPU0213
XU Jin;YU Feng;DAI De-zai;DAI Yin
XU Jin;YU Feng;DAI De-zai;DAI Yin
..............page:125-131
Statins:Pharmacokinetics and Pharmacokinetic Interactions with Other Drugs
ZHANG Wei-jie;TANG Wei-fang
ZHANG Wei-jie;TANG Wei-fang
..............page:119-124
Impurities in Compound Preparation of Chemical Drugs:Examination and Control
LIAN Fu-lin;LI Hong-xue;SHI Yue-qin;HU Yu-zhu
LIAN Fu-lin;LI Hong-xue;SHI Yue-qin;HU Yu-zhu
..............page:112-118